Abbott Acquires Visiogen for $400M
October 20, 2009 by Beckers ASC Review
Filed under Becker's ASC Review, Industry Updates
Abbott, based in Abbott Park, Ill., acquired Irvine, Calif.-based Visiogen for $400 million in cash, expanding the company’s vision care portfolio, according to an Abbott news release.
As part of the acquisition, Abbott will be provided with the next-generation accommodating intraocular lens technology to address presbyopia, an age-related change in vision in which the eye can no longer adjust its focal length to allow clear vision at different distances, for cataract patients, according to the release.
Visiogen’s accommodating IOL, Synchrony, is designed to “deliver improved vision at all distances,” according to the release, and may eliminate the patient’s need for glasses or contact lenses. Synchrony is designed to mimic the eyes’ natural ability to change focus and has the potential to deliver a full range of vision to the patient.
Read the news release about Abbott’s acquisition of Visiogen.
If you enjoyed this post, make sure you subscribe to my RSS feed!
 |
A post by "Becker's ASC Editor" http://www.beckersasc.com Becker's ASC Review is a bimonthly publication that offers general business, legal and clinical guidance on topics including joint-ventures, development and expansion, and regulatory and compliance issues. |
Wondering how this lens will do compared to the other accommodating lens (Crystalens)
This should be fun to watch!